Cellares

Fabian Gerlinghaus, CEO and Co-Founder Cellares is the world’s first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company has developed integrated technologies, the Cell Shuttle™ and Cell Q™, to automate the end-to-end manufacturing and quality control of cell therapy products. These technologies will be deployed in Cellares’ IDMO Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and make life-saving treatment more accessible to patients. The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing. www.cellares.com